For Brilliant Color: Packaging the First LSD Blotter
Admiration for the design and history of early LSD blotter art quickly broadens into a debate over what psychedelics actually do for people and society. Commenters contrast the emerging clinical evidence for treating anxiety, PTSD, addiction and end‑of‑life distress with decades of research bans, hype about “mind expansion,” and the practical difficulty of measuring creativity or improved cognition. Many emphasize set, setting, and individual vulnerability—highlighting risks such as psychosis, traumatic “bad trips,” and lasting perceptual changes—while others argue for legalization and careful regulation to enable safer, more informed use.
Blotter art, history, and culture
- Commenters connect the article to LSD blotter as visual art, including large private collections and institutional projects documenting designs.
- Some note the cleverness of the Kodachrome parody packaging and speculate about whether it’s parodying commercial “scientific product” language.
- Side discussions mention psychedelic music, the historical role of LSD in early Silicon Valley, and puns like “Psychedelicatessen.”
Legal constraints and research
- Several argue the “War on Drugs” and UN conventions, heavily driven by US policy, effectively chilled psychedelic research worldwide for decades.
- Others counter that modern research has restarted at major US institutions over the last ~20 years and that dismissing the field as “nonsense” ignores a growing peer‑reviewed literature.
Therapeutic and cognitive effects
- Some point to studies on psychedelics for anxiety, depression, PTSD, addiction, and end‑of‑life distress, and note FDA “breakthrough therapy” status for some uses.
- Others emphasize the lack of strong, objective evidence that LSD boosts intelligence, creativity, or work performance, and note it doesn’t appear in “doping” cultures like stimulants do.
- There’s debate over “neuroplasticity”: psychedelics may increase it, but one commenter quotes a researcher asking “who says plasticity is good?”
Creativity, consciousness, and self‑report
- Many stress that creativity and consciousness are hard to measure; effects may be indirect and long‑term, more like travel or profound life experiences.
- Skeptics highlight self‑delusion and mediocre output despite users’ belief in “breakthroughs,” and question grand claims about “higher realities.”
- Others argue the main value is subjective insight, altered perspective, and emotional processing, not productivity gains.
Experiences, set & setting, and integration
- Multiple users describe LSD and other psychedelics as powerful but unpredictable experiences, strongly dependent on mindset, environment, dose, and “integration” afterward.
- Some portray LSD as mostly recreational or empathogenic; others describe deep introspection, ego dissolution, and lasting attitude shifts (e.g., reduced prejudice).
Risks, mental health, and bad outcomes
- Numerous warnings: bad trips can be among the worst experiences of one’s life; psychedelics can exacerbate or unmask psychosis, especially schizophrenia‑spectrum vulnerabilities.
- Several report friends or relatives developing severe mental illness or dying after heavy use; others say their own use was benign but still wouldn’t recommend it casually.
- There’s explicit pushback against “cure‑all” hype; people stress screening for mental illness, careful dosing, and having support or sedatives available.
Practicalities: dosing, testing, and access
- Technical discussion touches on microgram‑level potency, blotter dosing methods, uneven distribution if sheets are soaked, and difficulty of detecting LSD in standard urine tests.
- Commenters note LSD’s legal status leads to purity issues (e.g., dangerous analogs) and wish for regulated, legal access to reduce substitution risk.